ClinicalTrials.gg
RecruitingNCT06196489Updated Jan 8, 2026

Adapting an Intervention for Vaping in Young Veterans

An interventional study of adapted vaping cessation intervention in E Cigarette Use, sponsored by Veterans Medical Research Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Veterans Medical Research Foundation · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 288 studies in Vaping with a site in United States — 66 open to participants now, 74 under way, 1 of them phase 3. Vaping · United States.

Planned enrollment
216th of 258
20 · median 71
Started
2024
with 30 others
No phase
206 of 288
39 open now
Primary completion
2026-06
later than 9 of 73 live
Registered
206th of 288
by date

Among the 288 studies in Vaping with a site in United States, this one is the 216th largest by planned enrollment of the 258 interventional ones that give a count, is one of 31 that started in 2024, is one of 206 with no phase, reaches primary completion later than 9 of the 73 other live ones, and was the 206th registered.

Vaping

404 studies on the registry are indexed under Vaping; 97 are open to participants now.

Browse Vaping studies →

Open to participants now

66 of the 288 studies in Vaping with a site in United States are open now. Recruiting first, the newest first:

61 more — sign in →

All 66 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 65 Vaping studies recruiting now, 33 (51%) set no upper age limit and 31 (48%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 288 studies in Vaping with a site in United States, or all of them as a file.
02

Study summary

The objective of this proposal is to adapt an evidence-based combustible tobacco counseling intervention following an evidence-based process to include e-cigarette use and update its components for emerging adults (EA).

  1. Examine factors related to e-cigarette use, barriers to cessation, and facilitators of use of cessation services among an EA population.
  2. Beta-test an initial version of the intervention, delivered via video telehealth and telephone, to examine usability and acceptability.
Read the detailed description

Use of electronic nicotine products (ENDS) has increased dramatically especially among young adults (EA- aged 18-30) and has been found to lead to immediate harmful health effects and increased addiction to combustible cigarette use. To date no research-tested interventions have been developed for helping people stop use of electronic nicotine products. Emerging adulthood is a developmental period that can lead to adoption of health risk behaviors.

This proposal aims to address nicotine addiction by adapting an evidence-based counseling cessation intervention developed by the American Cancer Society (ACS) for a general population of combustible tobacco smokers, but found to be effective in EA. We will test two methods of providing counseling to participants: video telehealth or telephone. Primary outcome: Compared to self-help guide only, at 3 month follow-up, we hypothesize that participants in either counseling arm will have higher rates as compared to self-help only control of 7-day abstinence from using any nicotine product.

This study fills a critical gap in ENDS research and will provide a model for further research into all-nicotine cessation in this vulnerable population.

03

Conditions studied

  • E Cigarette Use

Browse trials for

Keywords

  • Veteran
  • e-cigarette
  • vaping
  • young adult
04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • daily e-cigarette user for at least the past 6 months
  • 18-30 years old
  • willing to enroll in a program to quit nicotine use within 30 days
  • owns smartphone or computer/tablet with camera and internet connectivity
  • English speaker

Exclusion criteria

Exclusion Criteria:

  • ICD-10 diagnosis of dementia
  • current use of combustible tobacco products at least weekly
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    telephone

    Participants assigned to this group will receive the adapted intervention by telephone.

    Behavioral: adapted vaping cessation intervention

  • Experimental
    Video

    Participants assigned to this group will receive the adapted intervention by video telehealth.

    Behavioral: adapted vaping cessation intervention

Interventions

  • Behavioraladapted vaping cessation intervention

    Behavioral intervention for vaping cessation

06

What researchers measure

Primary outcomes

  1. e-cigarette use frequency

    number of days using e-cigarettes in the past 7 days at the time of assessment

    Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter

  2. e-cigarette use quantity

    number of e-cigarette uses per day

    Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter

  3. Client Satisfaction Questionnaire (CSQ-8)

    Participant satisfaction ratings; higher scores indicate greater satisfaction with the intervention

    Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter

07

Study locations

1 of 1 sites recruiting
  • Veterans Medical Research Foundation
    San Diego, California 92161, United States
    Recruiting
    • Neal Doran · Contactneal.doran@va.gov · 858-552-8585
    • Neal M Doran, PhD · Principal investigator
08

References and documents

Publications

  • Palmer AM, Tomko RL, Squeglia LM, Gray KM, Carpenter MJ, Smith TT, Dahne J, Toll BA, McClure EA. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 Mar 1;232:109311. doi: 10.1016/j.drugalcdep.2022.109311. Epub 2022 Jan 19. PubMed 35123362 ↗
  • Kinouani S, Leflot C, Vanderkam P, Auriacombe M, Langlois E, Tzourio C. Motivations for using electronic cigarettes in young adults: A systematic review. Subst Abus. 2020;41(3):315-322. doi: 10.1080/08897077.2019.1671937. Epub 2019 Oct 22. PubMed 31638872 ↗
  • Harrell PT, Brandon TH, Stark SE, Simmons VN, Barnett TE, Quinn GP, Chun S. Measuring vaping-related expectancies in young adults: Psychometric evaluation of the Electronic Nicotine Vaping Outcomes (ENVO) scale. Drug Alcohol Depend. 2023 May 1;246:109861. doi: 10.1016/j.drugalcdep.2023.109861. Epub 2023 Mar 29. PubMed 37028105 ↗
  • Cuccia AF, Patel M, Amato MS, Stephens DK, Yoon SN, Vallone DM. Quitting e-cigarettes: Quit attempts and quit intentions among youth and young adults. Prev Med Rep. 2021 Jan 5;21:101287. doi: 10.1016/j.pmedr.2020.101287. eCollection 2021 Mar. PubMed 33489721 ↗
  • Buu A, Hu YH, Wong SW, Lin HC. Comparing American college and noncollege young adults on e-cigarette use patterns including polysubstance use and reasons for using e-cigarettes. J Am Coll Health. 2020 Aug-Sep;68(6):610-616. doi: 10.1080/07448481.2019.1583662. Epub 2019 Mar 25. PubMed 30908151 ↗
  • Bandi P, Star J, Minihan AK, Patel M, Nargis N, Jemal A. Changes in E-Cigarette Use Among U.S. Adults, 2019-2021. Am J Prev Med. 2023 Aug;65(2):322-326. doi: 10.1016/j.amepre.2023.02.026. Epub 2023 Apr 18. PubMed 37479423 ↗

Individual participant data

Plan to share: No — Sample size is sufficiently small that sharing could threaten confidentiality.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Jun 2026, 29 months after the start.

Of 184 non-industry interventional studies with no phase under Vaping, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 29 months is above that.

Counting every sponsor, half of 208 studies reached it within 18 months; a quarter within 6 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2023
First posted
Jan 9, 2024
StartActual
Jan 1, 2024
Primary completionEst.
Jun 2026
CompletionEst.
Jun 2026
Last update
Jan 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06196489
Lead sponsor
Veterans Medical Research Foundation
Collaborators
University of California
Responsible party
Sponsor
First posted
Jan 9, 2024
Start date
Jan 1, 2024
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Jan 8, 2026

Study contacts

Neal M Doran, PhD
Contact
neal.doran@va.gov
858-552-8585
Neal M Doran, PhD
principal investigator · Veterans Medical Research Foundation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion